Gilead Sciences had a trading volume of $1.1 billion on February 19, ranking 84th among U.S. stocks on that day.

K-LinePoet · 2026-02-23T04:15:20+00:00

February 19, 2026, biotechnology company Gilead Sciences (GILD) had a trading volume of $1.10 billion, ranking 84th among U.S. stocks on that day. The trading volume increased by 38.54% compared to the previous day, with a daily trading volume of 7.2689 million shares.Gilead Sciences (GILD) fell 1.06% on February 19, 2026, to $151.12. The stock declined 0.45% over the past 5 trading days, increased 6.46% for the entire month of February, up 23.12% since the beginning of the year, and has risen 40.38% over the past 52 weeks.If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to the present (this also applies to companies listed for less than 1 month or fewer than 5 trading days).| Gilead Sciences (GILD) | Trading Volume / USD | Change in Trading Volume from Yesterday | Trading Volume || --- | --- |

K-LinePoet

2026-02-23 04:15:20

On February 19, 2026, biotech company Gilead Sciences (GILD) had a trading volume of $1.10 billion, ranking 84th among U.S. stocks for the day. The trading volume increased by 38.54% compared to the previous day, with a daily trading volume of 7.2689 million shares.

Gilead Sciences (GILD) closed at $151.12 on February 19, 2026, down 1.06%. Over the past five trading days, the stock declined by 0.45%. For February, it increased by 6.46%, and since the beginning of the year, it has risen by 23.12%. Over the past 52 weeks, it has gained 40.38%.

If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to the present (this also applies to listings less than 1 month or fewer than 5 trading days).

Gilead Sciences (GILD)	Trading Volume / USD	Change in Trading Volume from Yesterday	Shares Traded
February 19, 2026	$1.10 billion	38.54%	7.2689 million
February 18, 2026	$794 million	-12.74%	5.1909 million
February 17, 2026	$910 million	-14.51%	5.8852 million
February 13, 2026	$1.065 billion	-29.43%	6.8619 million
February 12, 2026	$1.509 billion	-14.93%	9.8912 million

Gilead Sciences was founded on June 22, 1987, in Delaware. It is a research-based biopharmaceutical company dedicated to discovering, developing, and commercializing innovative drugs to address unmet medical needs. The company’s main focus areas include viral diseases, inflammatory and fibrotic diseases, and oncology.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes